nipradilol has been researched along with 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ikeda, T; Kida, T; Kojima, S; Mizuno, K; Sugiyama, T | 1 |
1 other study(ies) available for nipradilol and 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole
Article | Year |
---|---|
Involvement of nitric oxide in the ocular hypotensive action of nipradilol.
Topics: Administration, Topical; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Anterior Chamber; Antihypertensive Agents; Aqueous Humor; Benzoates; Imidazoles; Intraocular Pressure; Nitric Oxide; Propanolamines; Rabbits; Sclera; Uvea; Vasodilator Agents | 2001 |